AngioDynamics, Inc. (ANGO) vs Ironwood Pharmaceuticals, Inc. (IRWD)
A side-by-side comparison of AngioDynamics, Inc. and Ironwood Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANGO
AngioDynamics, Inc.
$14.75HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
IRWD
Ironwood Pharmaceuticals, Inc.
$3.65HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — ANGO vs IRWD
growth of $100 · dividends reinvested · last 10yANGO -11.4% (-1.2%/yr)IRWD -77.1% (-13.7%/yr)ANGO compounded faster over this window
ANGO IRWD
ANGO vs IRWD: by the numbers
- •ANGO is the larger company ($609M vs $601M market cap).
- •IRWD is profitable (33.36% net margin) while ANGO runs a net loss (-11.48%).
- •ANGO grew revenue faster over the past five years (1.93% vs -1.18% CAGR).
Metrics side by side
Valuation
| Metric | ANGO | IRWD |
|---|---|---|
| P/E ratio | N/A | 4.76 |
| Forward P/E | N/A | 2.98 |
| P/S ratio | 1.90 | 1.54 |
| P/B ratio | 3.57 | N/A |
| EV / EBITDA | N/A | 3.86 |
| FCF yield | 0.08% | 30.88% |
Profitability
| Metric | ANGO | IRWD |
|---|---|---|
| Gross margin | 54.62% | 99.76% |
| Operating margin | -12.47% | 40.10% |
| Net margin | -11.48% | 33.36% |
| ROE | -21.51% | N/A |
| ROIC | -20.75% | 58.60% |
Growth (annualized)
| Metric | ANGO | IRWD |
|---|---|---|
| Revenue CAGR (5Y) | 1.93% | -1.18% |
| EPS CAGR (5Y) | N/A | -25.87% |
| FCF CAGR (5Y) | -51.49% | -3.98% |
| Total return CAGR (5Y) | -10.80% | -22.82% |
Frequently asked
- Which has grown faster, ANGO or IRWD?
- Over the past five years, ANGO grew revenue faster — ANGO at a 1.93% CAGR versus IRWD at -1.18%.
- Is ANGO or IRWD more profitable?
- IRWD runs the higher net margin — ANGO at -11.48% versus IRWD at 33.36%.
- How have ANGO and IRWD total returns compared?
- Over the past 10 years, ANGO delivered -0.58% and IRWD delivered -13.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Ironwood Pharmaceuticals P/E ratioAngioDynamics ROEIronwood Pharmaceuticals ROEAngioDynamics operating marginIronwood Pharmaceuticals operating marginAngioDynamics revenue growthIronwood Pharmaceuticals revenue growthAngioDynamics free cash flowIronwood Pharmaceuticals free cash flow
AngioDynamics & Ironwood Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.